Rapid Communication
Copyright ©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 7, 2007; 13(41): 5476-5480
Published online Nov 7, 2007. doi: 10.3748/wjg.v13.i41.5476
Table 1 Background of 26 cases of resected colorectal carcinoma
CaseGenderAge (yr)LocationTumour
1F49ColonAdenocarcinoma
2F70RectumAdenocarcinoma
3M86ColonAdenocarcinoma
4M76ColonAdenocarcinoma
5M73ColonAdenocarcinoma
6F76ColonAdenocarcinoma
7M72ColonAdenocarcinoma
8F68ColonAdenocarcinoma
9M72ColonAdenocarcinoma
10M50RectumAdenocarcinoma
11M88ColonAdenocarcinoma
12F68RectumAdenocarcinoma
13F48ColonAdenocarcinoma
14F75RectumAdenocarcinoma
15M37RectumAdenocarcinoma
16M57RectumAdenocarcinoma
17F71ColonAdenocarcinoma
18M70ColonAdenocarcinoma
19M47ColonAdenocarcinoma
20M47ColonAdenocarcinoma
21F71ColonAdenocarcinoma
22M53ColonAdenocarcinoma
23M80RectumAdenocarcinoma
24F49RectumAdenocarcinoma
25M76ColonAdenocarcinoma
26M62RectumAdenocarcinoma
Table 2 Results of histopathologic evaluation and flow cytometric analysis of NCAM-180 status
CasepTNMStageHistologyNCAM-180Outcome
1T3N0M0IIModerate-No active disease at 21 mo follow-up
2T4N1M1IVPoor-Died of metastatic diesease 8 mo postresection
3T4N2M1IVModerate-No active disease at 9 mo follow-up
4T3N0M0IIWell-No active disease at 20 mo follow-up
5T4NIM1IVPoor-Died of cardiopulmonary complication postoperatively
6T3N1M0IIIModerate-No active disease at 6 mo follow-up
7T2N0M0IModerate-Metachrone colonic disease at 15 mo
8T2N0M0IModerate-No active disease at 15 mo follow-up
9T4N2M0IIIModerate-Died of metastatic diesease 18 mo postresection
10T3N2M0IIIModerate-No active disease at 18 mo follow-up
11T2N0M0IModerate-Died of cardiopulmonary complication postoperatively
12T3N0M1IVPoor-Died of cardiopulmonary complication postoperatively
13T3N1M0IIIModerate-No active disease at 32 mo follow-up
14T3N1M0IIIModerate-No active disease at 20 mo follow-up
15T3N0M0IIPoor-No active disease at 16 mo follow-up
16T3N1M0IIIWell-No active disease at 19 mo follow-up
17T3N0M0IIWell+No active disease at 30 mofollow-up
18T3N1M0IIIWell-No active disease at 44 mo follow-up
19T4N2M1IVPoor-Died of metastatic diesease 5 mo postresection
20T4N2M1IVPoor-Died of metastatic diesease 4 mo postresection
21T3N0M0IIModerate-Died of metastatic diesease 56 mo postresection
22T4N1M1IVModerate-Died of metastatic diesease 15 mo postresection
23T4N1M0IIIModerate-Died of cardiopulmonary complication postoperatively
24T3N0M0IIPoor-No active disease at 18 mo follow-up
25T3N0M0IIModerate-No active disease at 16 mo follow-up
26T4N1M0IIIModerate-No active disease at 14 mo follow-up